252 related articles for article (PubMed ID: 34004031)
1. VGLL4 inhibits YAP1/TEAD signaling to suppress the epidermal squamous cell carcinoma cancer phenotype.
Mickle M; Adhikary G; Shrestha S; Xu W; Eckert RL
Mol Carcinog; 2021 Jul; 60(7):497-507. PubMed ID: 34004031
[TBL] [Abstract][Full Text] [Related]
2. Sulforaphane inhibits CD44v6/YAP1/TEAD signaling to suppress the cancer phenotype.
Chen X; Adhikary G; Ma E; Newland JJ; Naselsky W; Xu W; Eckert RL
Mol Carcinog; 2023 Feb; 62(2):236-248. PubMed ID: 36285644
[TBL] [Abstract][Full Text] [Related]
3. Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation.
Adhikary G; Shrestha S; Naselsky W; Newland JJ; Chen X; Xu W; Emadi A; Friedberg JS; Eckert RL
Mol Carcinog; 2023 Apr; 62(4):438-449. PubMed ID: 36562471
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
[TBL] [Abstract][Full Text] [Related]
5. TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors.
Edwards AC; Stalnecker CA; Jean Morales A; Taylor KE; Klomp JE; Klomp JA; Waters AM; Sudhakar N; Hallin J; Tang TT; Olson P; Post L; Christensen JG; Cox AD; Der CJ
Cancer Res; 2023 Dec; 83(24):4112-4129. PubMed ID: 37934103
[TBL] [Abstract][Full Text] [Related]
6. VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer.
Zhang Y; Shen H; Withers HG; Yang N; Denson KE; Mussell AL; Truskinovsky A; Fan Q; Gelman IH; Frangou C; Zhang J
Sci Rep; 2017 Jul; 7(1):6190. PubMed ID: 28733631
[TBL] [Abstract][Full Text] [Related]
7. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
Giraud J; Molina-Castro S; Seeneevassen L; Sifré E; Izotte J; Tiffon C; Staedel C; Boeuf H; Fernandez S; Barthelemy P; Megraud F; Lehours P; Dubus P; Varon C
Int J Cancer; 2020 Apr; 146(8):2255-2267. PubMed ID: 31489619
[TBL] [Abstract][Full Text] [Related]
8. The YAP1 Signaling Inhibitors, Verteporfin and CA3, Suppress the Mesothelioma Cancer Stem Cell Phenotype.
Kandasamy S; Adhikary G; Rorke EA; Friedberg JS; Mickle MB; Alexander HR; Eckert RL
Mol Cancer Res; 2020 Mar; 18(3):343-351. PubMed ID: 31732616
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase Interaction with α6/β4-Integrin Stimulates YAP1-Dependent ΔNp63α Stabilization and Leads to Enhanced Cancer Stem Cell Survival and Tumor Formation.
Fisher ML; Kerr C; Adhikary G; Grun D; Xu W; Keillor JW; Eckert RL
Cancer Res; 2016 Dec; 76(24):7265-7276. PubMed ID: 27780825
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of VGLL4 in the progression of esophageal squamous cell carcinoma.
Jiang W; Yao F; He J; Lv B; Fang W; Zhu W; He G; Chen J; He J
Tumour Biol; 2015 Feb; 36(2):1289-97. PubMed ID: 25352025
[TBL] [Abstract][Full Text] [Related]
11. Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease.
Simile MM; Latte G; Demartis MI; Brozzetti S; Calvisi DF; Porcu A; Feo CF; Seddaiu MA; Daino L; Berasain C; Tomasi ML; Avila MA; Feo F; Pascale RM
Oncotarget; 2016 Aug; 7(31):49194-49216. PubMed ID: 27359056
[TBL] [Abstract][Full Text] [Related]
12. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.
Ota M; Sasaki H
Development; 2008 Dec; 135(24):4059-69. PubMed ID: 19004856
[TBL] [Abstract][Full Text] [Related]
13. ACTL6A suppresses p21
Shrestha S; Adhikary G; Xu W; Kandasamy S; Eckert RL
Oncogene; 2020 Sep; 39(36):5855-5866. PubMed ID: 32616890
[TBL] [Abstract][Full Text] [Related]
14. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
Yan R; Liang ZW; Liu HS; Ge Y; An GY
Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
[No Abstract] [Full Text] [Related]
15. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.
Liu M; Zhang Y; Yang J; Zhan H; Zhou Z; Jiang Y; Shi X; Fan X; Zhang J; Luo W; Fung KA; Xu C; Bronze MS; Houchen CW; Li M
Gastroenterology; 2021 Apr; 160(5):1771-1783.e1. PubMed ID: 33421513
[TBL] [Abstract][Full Text] [Related]
16. YAP and TAZ are essential for basal and squamous cell carcinoma initiation.
Debaugnies M; Sánchez-Danés A; Rorive S; Raphaël M; Liagre M; Parent MA; Brisebarre A; Salmon I; Blanpain C
EMBO Rep; 2018 Jul; 19(7):. PubMed ID: 29875149
[TBL] [Abstract][Full Text] [Related]
17. Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion.
Vlahov N; Scrace S; Soto MS; Grawenda AM; Bradley L; Pankova D; Papaspyropoulos A; Yee KS; Buffa F; Goding CR; Timpson P; Sibson N; O'Neill E
Curr Biol; 2015 Dec; 25(23):3019-34. PubMed ID: 26549256
[TBL] [Abstract][Full Text] [Related]
18. YAP1/TAZ-TEAD transcriptional networks maintain skin homeostasis by regulating cell proliferation and limiting KLF4 activity.
Yuan Y; Park J; Feng A; Awasthi P; Wang Z; Chen Q; Iglesias-Bartolome R
Nat Commun; 2020 Mar; 11(1):1472. PubMed ID: 32193376
[TBL] [Abstract][Full Text] [Related]
19. VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs.
Deng X; Fang L
Am J Cancer Res; 2018; 8(6):932-943. PubMed ID: 30034932
[TBL] [Abstract][Full Text] [Related]
20. VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex.
Zhang W; Gao Y; Li P; Shi Z; Guo T; Li F; Han X; Feng Y; Zheng C; Wang Z; Li F; Chen H; Zhou Z; Zhang L; Ji H
Cell Res; 2014 Mar; 24(3):331-43. PubMed ID: 24458094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]